Anmeldung erfolgt in Kürze...
Details werden geladen...
Over 1,300 anti-cancer drugs to get cheaper - The Economic Times
India's National Pharmaceutical Pricing Authority is set to cap trade margins on anti-cancer drugs starting November 2026. The initiative aims to save around ₹2,500 crore annually for cancer patients. The list includes 1,366 drug brands, with substantial price reductions for several high-cost medications. However, some patented drugs will maintain their prices despite the changes. Patients and medical institutions are directed to display revised prices prominently.
Ähnliche Seiten
NPPA caps trade margins on 137 cancer drugs at 30%, revised prices from Nov 9 - The Economic Times
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/nppa-caps-trade-margins-on-137-cancer-drugs-at-30-revised-prices-from-nov-9/articleshow/135015811.cmsCancer drugs may get up to 70% cheaper as govt fixes trade margins on non-scheduled medicines at 30% - The Economic Times
https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/govt-prepares-to-cap-anti-cancer-drugs-trade-margins-at-30-of-mrp/articleshow/134795010.cms
Revised cancer drug prices kick in, patients set to save Rs 3,540 cr - The Tribune
https://www.tribuneindia.com/news/india/revised-cancer-drug-prices-kick-in-patients-set-to-save-rs-3540-cr/Cancer drug prices to fall by up to 96% from November 9; consumers set to save Rs 3,502 crore annually - The Economic Times
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/cancer-drug-prices-to-fall-by-up-to-96-from-november-9-consumers-set-to-save-rs-3502-crore-annually/articleshow/135636768.cmsCancer drug prices revised from today; patients may save Rs 3,540 crore annually - The Economic Times
https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/cancer-drug-prices-revised-from-today-patients-may-save-rs-3540-crore-annually/articleshow/135674332.cms